Your browser doesn't support javascript.
loading
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1).
Harrison, Stephen A; Thang, Carole; Bolze, Sébastien; Dewitt, Sheila; Hallakou-Bozec, Sophie; Dubourg, Julie; Bedossa, Pierre; Cusi, Kenneth; Ratziu, Vlad; Grouin, Jean-Marie; Moller, David E; Fouqueray, Pascale.
  • Harrison SA; Pinnacle Clinical Research, San Antonio, TX, USA.
  • Thang C; Poxel SA, Lyon, France.
  • Bolze S; Poxel SA, Lyon, France.
  • Dewitt S; DeutRx, Andover, MA, USA.
  • Hallakou-Bozec S; Poxel SA, Lyon, France. Electronic address: sophie.bozec@poxelpharma.com.
  • Dubourg J; Poxel SA, Lyon, France.
  • Bedossa P; Liverpat, Paris, France.
  • Cusi K; Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, USA.
  • Ratziu V; Sorbonne Université, ICAN, Hospital Pitié-Salpêtrière, INSERM UMRS 1138 CRC, Paris, France.
  • Grouin JM; Université de Rouen, 76000 Rouen, France.
  • Moller DE; Poxel SA, Lyon, France.
  • Fouqueray P; Poxel SA, Lyon, France.
J Hepatol ; 78(5): 914-925, 2023 05.
Article en En | MEDLINE | ID: mdl-36804402

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article